Loading…
A resolution honoring the life and achievements of Eugene A. "Gene" Cernan.
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
85pct
9d open
vs 747 other SRES bills in the 115th — cohort avg 12d
(This measure has not been amended since it was introduced. The summary of that version is repeated here.) Honors the life of Gene Cernan who was a Navy aviator, fighter pilot, electrical engineer, and the last astronaut to walk on the Moon.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2017 · fourth_quarter · Health Issues
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) H.Res. 539, Calling for sickle-cell trait research, surveillance, and public education and awareness S.Res. 27, Designating September 2017 as "Sickle Cell Disease Awareness Month" Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) American Health Care Act/Better Care Reconciliation Act/Health Care Freedom Act (H.R. 1628) Graham-Cassidy-Heller-Johnson Amendment re: ACA repeal/reform Bipartisan Health Care Stabilization Act (proposed by Senators Alexander and Murray) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions
Resolution agreed to in Senate without amendment and an amended preamble by Unanimous Consent. (text: CR S661)
Passed/agreed to in Senate: Resolution agreed to in Senate without amendment and an amended preamble by Unanimous Consent.(text: CR S661)
Measure laid before Senate by unanimous consent. (consideration: CR S660-661)
Senate Committee on the Judiciary discharged by Unanimous Consent.
Senate Committee on the Judiciary discharged by Unanimous Consent.
Referred to the Committee on the Judiciary. (text of measure as introduced: CR S455)
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $30,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2017 · third_quarter · Medical/Disease Research/Clinical Labs
Sickle Cell Disease/Trait Issues Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) H.Res. 539, Calling for sickle-cell trait research, surveillance, and public education and awareness S.Res.27, Designating September 2017 as "Sickle Cell Disease Awareness Month" Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations Regulation of Laboratory Developed Tests Cancer "Moonshot" Initiative
Client expense: $30,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2017 · third_quarter · Health Issues
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) H.Res. 539, Calling for sickle-cell trait research, surveillance, and public education and awareness S.Res. 27, Designating September 2017 as "Sickle Cell Disease Awareness Month" Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) American Health Care Act/Better Care Reconciliation Act/Health Care Freedom Act (H.R. 1628) Graham-Cassidy-Heller-Johnson Amendment re: ACA repeal/reform Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions
Client expense: $30,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
| Democratic |
| MI |
| James M. Inhofe | Republican | OK |
| John Cornyn | Republican | TX |
| John Thune | Republican | SD |
| Marco Rubio | Republican | FL |
| Margaret Wood Hassan | Democratic | NH |
| Richard J. Durbin | Democratic | IL |
| Roger F. Wicker | Republican | MS |